Options for medical treatment of myomas

被引：19

作者：

Rackow, BW ^{[1
]}

Arici, A ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2006年 / 33卷 / 01期

关键词：

D O I：

10.1016/j.ogc.2005.12.014

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Uterine myomas are a prevalent issue for women of reproductive age. For patients who desire future fertility or conservative management of myomas, medical therapies can be an effective management option. Estrogen and progesterone impact myoma growth and development, and current medical therapies manipulate these steroid hormones to affect myoma size and abnormal bleeding. Future therapies are likely to target more specific hormone regulation, growth factors, or gene regulation.

引用

页码：97 / +

页数：18

共 69 条

[1] Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles [J].

Baker, VL ;

Draper, M ;

Paul, S ;

Allerheiligen, S ;

Glant, M ;

Shifren, J ;

Jaffe, RB .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :6-13

[2]

BUTTRAM VC, 1981, FERTIL STERIL, V36, P433

[3] AN EVALUATION OF THE EFFECT OF GONADOTROPIN-RELEASING-HORMONE ANALOGS AND MEDROXYPROGESTERONE ACETATE ON UTERINE LEIOMYOMATA VOLUME BY MAGNETIC-RESONANCE-IMAGING - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL [J].

CARR, BR ;

MARSHBURN, PB ;

WEATHERALL, PT ;

BRADSHAW, KD ;

BRESLAU, NA ;

BYRD, W ;

ROARK, M ;

STEINKAMPF, MP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (05) :1217-1223

[4] Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-β expression [J].

Chegini, N ;

Ma, C ;

Tang, XM ;

Williams, RS .

MOLECULAR HUMAN REPRODUCTION, 2002, 8 (12) :1071-1078

[5] Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis [J].

Chwalisz, K ;

Perez, MC ;

DeManno, D ;

Winkel, C ;

Schubert, G ;

Elger, W .

ENDOCRINE REVIEWS, 2005, 26 (03) :423-438

[6]

Chwalisz K, 2004, SEMIN REPROD MED, V22, P113

[7]

Chwalisz K, 2003, J SOC GYNECOL INVEST, V10, p301A

[8] GnRH antagonists [J].

Coccia, ME ;

Comparetto, C ;

Bracco, GL ;

Scarselli, G .

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 115 :S44-S56

[9]

Cook JD, 2004, SEMIN REPROD MED, V22, P105

[10] REGRESSION OF UTERINE LEIOMYOMAS AFTER TREATMENT WITH GESTRINONE, AN ANTIESTROGEN, ANTIPROGESTERONE [J].

COUTINHO, EM ;

BOULANGER, GA ;

GONCALVES, MT .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (04) :761-767

← 1 2 3 4 5 6 7 →